688278 特宝生物
已收盘 07-22 15:00:00
资讯
新帖
简况
国产创新药板块里程碑进展频现,创新药ETF(159992)跟踪指数逆市上涨,浙江医药、君实生物-U、特宝生物领涨。
和讯网 · 07-18
国产创新药板块里程碑进展频现,创新药ETF(159992)跟踪指数逆市上涨,浙江医药、君实生物-U、特宝生物领涨。
独家药品概念盘中跳水,特宝生物跌0.49%
自选股智能写手 · 07-18
独家药品概念盘中跳水,特宝生物跌0.49%
特宝生物:7月17日接受机构调研,招商基金参与
证券之星 · 07-18
特宝生物:7月17日接受机构调研,招商基金参与
特宝生物(688278)派格宾布局持续拓展,大单品展现广阔空间
兴业证券 · 07-17
特宝生物(688278)派格宾布局持续拓展,大单品展现广阔空间
特宝生物(688278.SH)董事兰春完成减持 累计减持38万股
智通财经 · 07-15
特宝生物(688278.SH)董事兰春完成减持 累计减持38万股
特宝生物:董事兰春承诺6个月内不减持公司股份
E公司 · 07-15
特宝生物:董事兰春承诺6个月内不减持公司股份
特宝生物:7月15日高管兰春减持股份合计38万股
证券之星 · 07-15
特宝生物:7月15日高管兰春减持股份合计38万股
肝炎概念盘中跳水,特宝生物跌1.13%
自选股智能写手 · 07-15
肝炎概念盘中跳水,特宝生物跌1.13%
【机构调研记录】金鹰基金调研特宝生物、东山精密等3只个股(附名单)
证券之星 · 07-15
【机构调研记录】金鹰基金调研特宝生物、东山精密等3只个股(附名单)
【机构调研记录】易方达基金调研特宝生物、纳芯微等4只个股(附名单)
证券之星 · 07-15
【机构调研记录】易方达基金调研特宝生物、纳芯微等4只个股(附名单)
肝炎概念盘中拉升,特宝生物涨2.11%
自选股智能写手 · 07-09
肝炎概念盘中拉升,特宝生物涨2.11%
特宝生物(688278.SH):派格宾新增适应症获得药物临床试验批准通知书
智通财经网 · 07-07
特宝生物(688278.SH):派格宾新增适应症获得药物临床试验批准通知书
7月5日特宝生物现1笔大宗交易 机构净买入1063.8万元
证券之星 · 07-05
7月5日特宝生物现1笔大宗交易 机构净买入1063.8万元
7月5日特宝生物涨6.02%,东方红睿丰LOF基金重仓该股
证券之星 · 07-05
7月5日特宝生物涨6.02%,东方红睿丰LOF基金重仓该股
独家药品概念盘中跳水,特宝生物跌1.29%
自选股智能写手 · 07-04
独家药品概念盘中跳水,特宝生物跌1.29%
特宝生物7月2日转融通出借成交3600股
金融界 · 07-03
特宝生物7月2日转融通出借成交3600股
特宝生物(688278):乙肝干扰素治疗龙头 深耕重组蛋白药物开发
海通证券股份有... · 06-27
特宝生物(688278):乙肝干扰素治疗龙头 深耕重组蛋白药物开发
调研早知道|一项技术价值凸显,这家生物科技公司将持续受益
界面 · 06-20
调研早知道|一项技术价值凸显,这家生物科技公司将持续受益
特宝生物:相关研发项目后续如涉及需披露事项,公司将按有关规定及时履行信息披露义务
证券之星 · 06-19
特宝生物:相关研发项目后续如涉及需披露事项,公司将按有关规定及时履行信息披露义务
6月19日特宝生物现1笔折价18.05%的大宗交易 合计成交4394.37万元
证券之星 · 06-19
6月19日特宝生物现1笔折价18.05%的大宗交易 合计成交4394.37万元
公司概况
公司名称:
厦门特宝生物工程股份有限公司
所属行业:
医药制造业
上市日期:
2020-01-17
主营业务:
厦门特宝生物工程股份有限公司是一家主要从事重组蛋白质及其长效修饰药物研发、生产及销售的国家创新型生物医药企业,已开发完成4个治疗用生物技术产品派格宾、特尔立、特尔津、特尔康,用于病毒性肝炎、恶性肿瘤等疾病的治疗。派格宾的药物研发及相关临床应用得到了4项“重大新药创制”国家科技重大专项的支持,拥有独创的结构设计及完整的专利保护,突破了国外医药巨头的专利封锁,入选中国医药生物技术协会评选的当年度“中国医药生物技术十大进展”。公司是重组人粒细胞巨噬细胞刺激因子、重组人粒细胞刺激因子、重组人白介素-11、重组人干扰素a2a、重组人干扰素a2b等多个国家标准物质的原料提供单位;多次参与国家同质标准品的研制和协作标定。此外,公司多次参与美国药典委员会(USP)、世界卫生组织(WHO)等国际机构组织的标准品协作标定。
发行价格:
8.24
{"stockData":{"symbol":"688278","market":"SH","secType":"STK","nameCN":"特宝生物","latestPrice":57.19,"timestamp":1721631600000,"preClose":57.13,"halted":0,"volume":1445772,"delay":0,"floatShares":407000000,"shares":407000000,"eps":1.4752,"marketStatus":"已收盘","marketStatusCode":5,"change":0.06,"latestTime":"07-22 15:00:00","open":57,"high":57.92,"low":56.65,"amount":82852800,"amplitude":0.0222,"askPrice":57.19,"askSize":18,"bidPrice":57.13,"bidSize":4,"shortable":0,"etf":0,"ttmEps":1.4752,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721698200000},"adr":0,"adjPreClose":57.13,"symbolType":"stock_kcb","openAndCloseTimeList":[[1721611800000,1721619000000],[1721624400000,1721631600000]],"highLimit":62.84,"lowLimit":51.42,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":406800000,"pbRate":11.6,"roa":"--","roe":"6.64%","epsLYR":1.37,"committee":-0.166667,"marketValue":23265000000,"floatMarketCap":23265000000,"peRate":38.767623,"changeRate":0.0011,"turnoverRate":0.0036,"status":0,"afterMarket":{"amount":0,"volume":0,"close":57.19,"buyVolume":0,"sellVolume":0,"time":1721633637153,"indexStatus":"已收盘 07-22 15:30:00","preClose":57.13}},"requestUrl":"/m/hq/s/688278/wiki","defaultTab":"wiki","newsList":[{"id":"2452220125","title":"国产创新药板块里程碑进展频现,创新药ETF(159992)跟踪指数逆市上涨,浙江医药、君实生物-U、特宝生物领涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2452220125","media":"和讯网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452220125?lang=zh_cn&edition=full","pubTime":"2024-07-18 11:03","pubTimestamp":1721271813,"startTime":"0","endTime":"0","summary":"2024年7月18日,创新药板块逆市大涨。盘面上,浙江医药领涨,君实生物-U、特宝生物跟涨,创新药ETF市场热度较高,过去5个交易日日均成交额2.24亿元。西南证券表示,重要产品的里程碑进展和临床数据披露是股价的重要催化剂。下半年,A股多家药企将有众多里程碑进展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071812461895d3120c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071812461895d3120c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","BK0028","688180","600216","688278","BK0188","BK0191","515120","159992"],"gpt_icon":0},{"id":"2452146396","title":"独家药品概念盘中跳水,特宝生物跌0.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452146396","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452146396?lang=zh_cn&edition=full","pubTime":"2024-07-18 09:52","pubTimestamp":1721267566,"startTime":"0","endTime":"0","summary":"07月18日,独家药品概念盘中跳水,截至09点52分,独家药品概念整体指数下跌0.52%,报763.180点。从个股上来看,该概念的成分股中,特宝生物跌0.49%,广誉远、佐力药业、云南白药跌幅居前。从资金上来看,截止发稿,独家药品概念概念主力净流入为-2894.21万,其中华润三九受到资金热捧,主力净流入473.31万;拉长时间线来看,该板块近20日主力资金净流入-29.02亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407180952469681de01&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407180952469681de01&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688278","BK0239"],"gpt_icon":0},{"id":"2452316022","title":"特宝生物:7月17日接受机构调研,招商基金参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2452316022","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452316022?lang=zh_cn&edition=full","pubTime":"2024-07-18 01:22","pubTimestamp":1721236942,"startTime":"0","endTime":"0","summary":"证券之星消息,2024年7月17日特宝生物发布公告称公司于2024年7月17日接受机构调研,招商基金参与。主要原因是2023年对外捐赠同比有所减少。目前未有第三方相关公开统计数据。派格宾目前覆盖的医院和药房约3000家。特宝生物2024年一季报显示,公司主营收入5.45亿元,同比上升30.05%;归母净利润1.29亿元,同比上升53.03%;扣非净利润1.46亿元,同比上升42.9%;负债率17.38%,投资收益139.64万元,财务费用-75.09万元,毛利率93.07%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071800001837.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688278","BK0239"],"gpt_icon":0},{"id":"2452690944","title":"特宝生物(688278)派格宾布局持续拓展,大单品展现广阔空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2452690944","media":"兴业证券","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452690944?lang=zh_cn&edition=full","pubTime":"2024-07-17 12:16","pubTimestamp":1721189809,"startTime":"0","endTime":"0","summary":"盈利预测与估值:公司是中国聚乙二醇蛋白质长效药物领域的领军企业,派格宾持续展现乙肝治愈证据,有望通过渗透率提升和适应症拓展持续打开空间,佩金、长效生长激素等产品有望未来为公司的长期增长提供保障。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071712293895cc5c23&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071712293895cc5c23&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688278"],"gpt_icon":0},{"id":"2451626262","title":"特宝生物(688278.SH)董事兰春完成减持 累计减持38万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2451626262","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451626262?lang=zh_cn&edition=full","pubTime":"2024-07-15 22:27","pubTimestamp":1721053634,"startTime":"0","endTime":"0","summary":"智通财经APP讯,特宝生物(688278.SH)公告,公司董事兰春先生减持计划已实施完毕,其通过集中竞价方式累计减持公司股份38万股。兰春先生自愿承诺自2024年7月15日起6个月内不通过二级市场、大宗交易减持其直接持有的公司股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1151243.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","688278"],"gpt_icon":0},{"id":"2451094625","title":"特宝生物:董事兰春承诺6个月内不减持公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2451094625","media":"E公司","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451094625?lang=zh_cn&edition=full","pubTime":"2024-07-15 22:16","pubTimestamp":1721052960,"startTime":"0","endTime":"0","summary":"e公司讯,特宝生物(688278)7月15日晚间公告,公司董事兰春基于对公司未来发展前景的信心和长期投资价值的认可,自愿承诺自7月15日起6个月内不通过二级市场、大宗交易减持其直接持有的公司股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715221647af926645&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715221647af926645&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688278","BK0239"],"gpt_icon":0},{"id":"2451623475","title":"特宝生物:7月15日高管兰春减持股份合计38万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2451623475","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451623475?lang=zh_cn&edition=full","pubTime":"2024-07-15 22:00","pubTimestamp":1721052055,"startTime":"0","endTime":"0","summary":"证券之星消息,根据7月15日市场公开信息、上市公司公告及交易所披露数据整理,特宝生物最新董监高及相关人员股份变动情况:2024年7月15日公司董事兰春共减持公司股份38.0万股,占公司总股本为0.0934%。变动期间公司股价下跌0.57%,7月15日当日收盘报56.2元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071500031935.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688278"],"gpt_icon":0},{"id":"2451552665","title":"肝炎概念盘中跳水,特宝生物跌1.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451552665","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451552665?lang=zh_cn&edition=full","pubTime":"2024-07-15 10:22","pubTimestamp":1721010120,"startTime":"0","endTime":"0","summary":"07月15日,肝炎概念盘中跳水,截至10点21分,肝炎概念整体指数下跌2.01%,报735.070点。从个股上来看,该概念的成分股中,特宝生物跌1.13%,华大基因、千金药业、安科生物跌幅居前。从资金上来看,截止发稿,肝炎概念概念主力净流入为-1.09亿,其中人福医药受到资金热捧,主力净流入1184.18万;拉长时间线来看,该板块近20日主力资金净流入-20.11亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715102200941f6f25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715102200941f6f25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688278"],"gpt_icon":0},{"id":"2451654567","title":"【机构调研记录】金鹰基金调研特宝生物、东山精密等3只个股(附名单)","url":"https://stock-news.laohu8.com/highlight/detail?id=2451654567","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451654567?lang=zh_cn&edition=full","pubTime":"2024-07-15 08:02","pubTimestamp":1721001761,"startTime":"0","endTime":"0","summary":"3)水晶光电 个股亮点:公司拥有微投技术,并且公司正在推进视频眼镜项目;公司为三星S24和PPO find x7的机型供应光学零组件产品。;公司主要产品应用于数码相机、手机摄像头等金鹰基金成立于2002年,截至目前,资产管理规模629.63亿元,排名75/204;资产管理规模420.12亿元,排名77/204;管理公募基金数125只,排名54/204;旗下公募基金经理22人,排名60/204。旗下最近一年表现最佳的公募基金产品为金鹰周期优选混合A,最新单位净值为0.84,近一年增长16.34%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071500001485.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0109","688278","002384","BK0152","BK0239","BK0141","BK0214","BK0076","BK0171","BK0196"],"gpt_icon":0},{"id":"2451654558","title":"【机构调研记录】易方达基金调研特宝生物、纳芯微等4只个股(附名单)","url":"https://stock-news.laohu8.com/highlight/detail?id=2451654558","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451654558?lang=zh_cn&edition=full","pubTime":"2024-07-15 08:02","pubTimestamp":1721001739,"startTime":"0","endTime":"0","summary":";公司主要产品应用于数码相机、手机摄像头等易方达基金成立于2001年,截至目前,资产管理规模18003.31亿元,排名1/204;资产管理规模10643.15亿元,排名1/204;管理公募基金数714只,排名3/204;旗下公募基金经理85人,排名6/204。旗下最新募集公募基金产品为易方达上证科创板100ETF联接发起式A,类型为指数型-股票,集中认购期2024年7月15日至2024年8月2日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071500001448.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688052","BK0231","BK0239","688278"],"gpt_icon":0},{"id":"2450055661","title":"肝炎概念盘中拉升,特宝生物涨2.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450055661","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450055661?lang=zh_cn&edition=full","pubTime":"2024-07-09 09:42","pubTimestamp":1720489339,"startTime":"0","endTime":"0","summary":"07月09日,肝炎概念盘中拉升,截至09点42分,肝炎概念整体指数上涨0.52%,报725.890点。从个股上来看,该概念的成分股中,特宝生物涨2.11%,健帆生物、ST百灵、双成药业涨幅居前。从资金上来看,截止发稿,肝炎概念概念主力净流入为-669.66万,其中健帆生物受到资金热捧,主力净流入695.51万;拉长时间线来看,该板块近20日主力资金净流入-20.24亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709094219941f5152&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709094219941f5152&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688278","BK0239"],"gpt_icon":0},{"id":"2449755310","title":"特宝生物(688278.SH):派格宾新增适应症获得药物临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2449755310","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449755310?lang=zh_cn&edition=full","pubTime":"2024-07-07 16:28","pubTimestamp":1720340880,"startTime":"0","endTime":"0","summary":"特宝生物(688278.SH)发布公告,该公司于近日收到国家药品监督管理局(以下简...","market":"us","thumbnail":"https://img.zhitongcaijing.com/astock/19.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astock/19.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1146605.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1576","BK1583","BK1141","03347","688278","BK0239"],"gpt_icon":0},{"id":"2449597102","title":"7月5日特宝生物现1笔大宗交易 机构净买入1063.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449597102","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449597102?lang=zh_cn&edition=full","pubTime":"2024-07-05 17:20","pubTimestamp":1720171239,"startTime":"0","endTime":"0","summary":"证券之星消息,7月5日特宝生物发生大宗交易,交易数据如下:大宗交易成交价格53.19元,相对当日收盘价折价2.01%,成交20万股,成交金额1063.8万元,买方营业部为机构专用,卖方营业部为国金证券股份有限公司上海浦东新区梅花路证券营业部。近三个月该股共发生5笔大宗交易,合计成交2.04万手,折价成交5笔。截至2024年7月5日收盘,特宝生物报收于54.28元,上涨6.02%,换手率0.55%,成交量2.22万手,成交额1.18亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705172144957b92bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705172144957b92bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688278","BK0239"],"gpt_icon":0},{"id":"2449538692","title":"7月5日特宝生物涨6.02%,东方红睿丰LOF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2449538692","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449538692?lang=zh_cn&edition=full","pubTime":"2024-07-05 16:15","pubTimestamp":1720167353,"startTime":"0","endTime":"0","summary":"证券之星消息,7月5日特宝生物涨6.02%,收盘报54.28元,换手率0.55%,成交量2.22万手,成交额1.18亿元。重仓特宝生物的前十大公募基金请见下表:该股最近90天内共有6家机构给出评级,买入评级5家,增持评级1家;过去90天内机构目标均价为84.06。根据2024基金Q1季报公募基金重仓股数据,重仓该股的公募基金共39家,其中持有数量最多的公募基金为东方红睿丰LOF。东方红睿丰LOF目前规模为18.33亿元,最新净值1.188,较上一交易日上涨0.25%,近一年下跌20.32%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070500029565.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688278","BK0239"],"gpt_icon":0},{"id":"2448949897","title":"独家药品概念盘中跳水,特宝生物跌1.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448949897","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448949897?lang=zh_cn&edition=full","pubTime":"2024-07-04 11:28","pubTimestamp":1720063732,"startTime":"0","endTime":"0","summary":"07月04日,独家药品概念盘中跳水,截至11点28分,独家药品概念整体指数下跌2.01%,报753.880点。从个股上来看,该概念的成分股中,特宝生物跌1.29%,亿帆医药、西藏药业、华邦健康跌幅居前。从资金上来看,截止发稿,独家药品概念概念主力净流入为-1.88亿,其中同仁堂受到资金热捧,主力净流入424.60万;拉长时间线来看,该板块近20日主力资金净流入-40.62亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024070411285296819728&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024070411285296819728&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688278"],"gpt_icon":0},{"id":"2448112260","title":"特宝生物7月2日转融通出借成交3600股","url":"https://stock-news.laohu8.com/highlight/detail?id=2448112260","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448112260?lang=zh_cn&edition=full","pubTime":"2024-07-03 09:04","pubTimestamp":1719968684,"startTime":"0","endTime":"0","summary":"根据上交所网站显示,7月2日,特宝生物转融通出借成交3600股,期限为14天。据了解,转融通是指证券金融公司将自有或者依法筹集的资金和证券出借给证券公司,以供其办理融资融券业务的经营活动。上交所接受借入人借入申报的时间为每个交易日 9:15 至 11:30、13:00 至 15:10。公开资料显示,特宝生物法人代表为孙黎,公司注册资本4.07亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407030904499ef84559&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407030904499ef84559&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688278","BK0239"],"gpt_icon":0},{"id":"2446327654","title":"特宝生物(688278):乙肝干扰素治疗龙头 深耕重组蛋白药物开发","url":"https://stock-news.laohu8.com/highlight/detail?id=2446327654","media":"海通证券股份有...","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446327654?lang=zh_cn&edition=full","pubTime":"2024-06-27 10:01","pubTimestamp":1719453668,"startTime":"0","endTime":"0","summary":"特宝生物是一家专注于长效重组蛋白药物研发、生产和销售的生物科技公司,目前拥有5款重组蛋白上市产品,包括治疗血液肿瘤相关疾病的特尔津、特尔康、特尔立、珮金,以及治疗慢性病毒性肝炎的派格宾。慢乙肝临床治愈空间不断扩大,看好派格宾未来持续放量。根据我们测算,派格宾上市以来累计覆盖优势患者数量不超过15万人,渗透率仅为6-10%。长效生长激素已于2024年1月11日递交上市申请并获得受理。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062710011395dc4b82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062710011395dc4b82&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688278"],"gpt_icon":0},{"id":"2444233729","title":"调研早知道|一项技术价值凸显,这家生物科技公司将持续受益","url":"https://stock-news.laohu8.com/highlight/detail?id=2444233729","media":"界面","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444233729?lang=zh_cn&edition=full","pubTime":"2024-06-20 09:15","pubTimestamp":1718846100,"startTime":"0","endTime":"0","summary":"长效修饰技术成为近期生物科技领域的小亮点。派格宾,全球首个40kD聚乙二醇干扰素α-2b注射液,这种药物通过聚乙二醇化技术改进了普通干扰素的分子结构,实现了肝病药物的长效化。2023年,派格宾销售达到了17.9亿元人民币,同比增长54%;开发这一产品的生物科技公司特宝生物也受益良多。日前,公司举行投资者关系活动,介绍更多有关派格宾的信息。这些策略旨在提高治疗效果,增强派格宾的市场竞争力,从而推动销售增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062009165795c37221&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062009165795c37221&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159837","688278","BK0239"],"gpt_icon":0},{"id":"2444427932","title":"特宝生物:相关研发项目后续如涉及需披露事项,公司将按有关规定及时履行信息披露义务","url":"https://stock-news.laohu8.com/highlight/detail?id=2444427932","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444427932?lang=zh_cn&edition=full","pubTime":"2024-06-19 19:01","pubTimestamp":1718794910,"startTime":"0","endTime":"0","summary":"证券之星消息,特宝生物(688278)06月19日在投资者关系平台上答复投资者关心的问题。投资者:董秘您好,好久不见,派格宾在药物审核中心新受理了一个临床,受理号是CXSL2400270,请问这是一个什么临床项目呢?特宝生物董秘:投资者您好!相关研发项目后续如涉及需披露事项,公司将按有关规定及时履行信息披露义务,感谢您的关注。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406191903079f4e7b20&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406191903079f4e7b20&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688278","BK0239"],"gpt_icon":0},{"id":"2444868426","title":"6月19日特宝生物现1笔折价18.05%的大宗交易 合计成交4394.37万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444868426","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444868426?lang=zh_cn&edition=full","pubTime":"2024-06-19 17:20","pubTimestamp":1718788850,"startTime":"0","endTime":"0","summary":"证券之星消息,6月19日特宝生物发生大宗交易,交易数据如下:大宗交易成交价格46.59元,相对当日收盘价折价18.05%,成交94.32万股,成交金额4394.37万元,买方营业部为东莞证券股份有限公司上海广东路证券营业部,卖方营业部为东莞证券股份有限公司上海广东路证券营业部。近三个月该股共发生4笔大宗交易,合计成交1.84万手,折价成交4笔。截至2024年6月19日收盘,特宝生物报收于56.85元,下跌2.37%,换手率0.36%,成交量1.47万手,成交额8415.45万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024061900035737.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688278","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-01-17","address":"福建省厦门市海沧区新阳工业区翁角路330号","stockEarnings":[{"period":"1week","weight":0.0108},{"period":"1month","weight":0.0049},{"period":"3month","weight":-0.0818},{"period":"6month","weight":0.029},{"period":"1year","weight":0.3839},{"period":"ytd","weight":0.0992}],"companyName":"厦门特宝生物工程股份有限公司","boardCode":"AI0027","perCapita":"53301股","boardName":"医药制造业","registeredCapital":"40680万元","compareEarnings":[{"period":"1week","weight":0.0037},{"period":"1month","weight":-0.0118},{"period":"3month","weight":-0.0271},{"period":"6month","weight":0.053},{"period":"1year","weight":-0.0591},{"period":"ytd","weight":0.0025}],"survey":" 厦门特宝生物工程股份有限公司是一家主要从事重组蛋白质及其长效修饰药物研发、生产及销售的国家创新型生物医药企业,已开发完成4个治疗用生物技术产品派格宾、特尔立、特尔津、特尔康,用于病毒性肝炎、恶性肿瘤等疾病的治疗。派格宾的药物研发及相关临床应用得到了4项“重大新药创制”国家科技重大专项的支持,拥有独创的结构设计及完整的专利保护,突破了国外医药巨头的专利封锁,入选中国医药生物技术协会评选的当年度“中国医药生物技术十大进展”。公司是重组人粒细胞巨噬细胞刺激因子、重组人粒细胞刺激因子、重组人白介素-11、重组人干扰素a2a、重组人干扰素a2b等多个国家标准物质的原料提供单位;多次参与国家同质标准品的研制和协作标定。此外,公司多次参与美国药典委员会(USP)、世界卫生组织(WHO)等国际机构组织的标准品协作标定。","serverTime":1721647028930,"listedPrice":8.24,"stockholders":"7632人(较上一季度减少0.29%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"特宝生物(688278)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供特宝生物(688278)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"特宝生物,688278,特宝生物股票,特宝生物股票老虎,特宝生物股票老虎国际,特宝生物行情,特宝生物股票行情,特宝生物股价,特宝生物股市,特宝生物股票价格,特宝生物股票交易,特宝生物股票购买,特宝生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"特宝生物(688278)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供特宝生物(688278)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}